Colloid & dispersion stabilization
A small materialholds a big change.
Active stabilization · improved bioavailability · reduced side effects
BigBasin uses colloid and dispersion stabilization to bring poorly soluble actives into a stable dispersed state without modifying the molecule. Loaded into a biodegradable carrier, the active stays stable in storage and is released and degraded as designed in use. Our ultimate target is the injectable formulation of poorly soluble drugs.
What we do
Stable dispersion, without modifying the molecule
At the core of BigBasin is colloid and dispersion stabilization. We bring poorly soluble actives into a stable dispersed state without altering them chemically, protecting them from oxidation and loss while improving bioavailability. Biodegradable polymers are only one of the carriers we use; our real asset is material-agnostic interfacial and particle design. An active held in the carrier stays stable in storage, is released at the designed rate in use, and the carrier then degrades as designed. The ultimate goal of this technology is the injectable formulation of poorly soluble drugs, and the stabilized dispersion also helps reduce side effects.
Applications
- 01
Injectables & drug delivery
Our ultimate goal: loading poorly soluble drugs into a biodegradable carrier without molecular modification, dispersing them in water with a designed release rate, toward injectable formulations.
- 02
Cosmetics & fragrance
One encapsulation technology stabilizes sensitive actives and volatile aroma molecules, with engineered release timing and rate.
- 03
Next-gen polymers & composites
An open field spanning polymer synthesis and modification, functional composites, and colloid-interface analysis.
Why our technology
Why BigBasin dispersion stabilization
- 01
Modification-free dispersion, stabilized actives
We bring poorly soluble substances into a stable dispersed state without altering the molecule, protecting them from oxidation and loss.
- 02
Stable in storage, functional in use, degrades by design
An active held in a biodegradable carrier stays stable in storage, is released at the designed rate in use, and the carrier then degrades as designed.
- 03
Improved bioavailability
Stable nanodispersion enhances absorption and delivery efficiency.
- 04
Injectable-oriented, fewer side effects
Targeting injectable formulations of poorly soluble drugs, with stabilized dispersion helping reduce side effects.
Team
Deep-tech bridging: from lab to market
-
Chan Ho Park Founder & CEO - Hanna Lee Head of Research
-
Soo-Kyung Han Researcher
We're looking for partners to build with
If you are interested in joint research, business partnerships, or investment, please reach out.
Get in touch